Moderate to Severe Inflammatory Acne Vulgaris: Comprehensive Pipeline Analysis, Clinical Studies, Leading Companies, Therapeutic Evaluation, Novel Treatments, and Development Insights | Sagimet Biosciences, Boston Pharmaceuticals, Shanghai Fudan-Zhangjiang | #healthcare